Brickell Biotech, Inc.·4

May 19, 5:02 PM ET

McAvoy David R. 4

4 · Brickell Biotech, Inc. · Filed May 19, 2021

Insider Transaction Report

Form 4
Period: 2021-05-17
McAvoy David R.
General Counsel
Transactions
  • Purchase

    Common Stock

    2021-05-17$0.80/sh+7,980$6,38413,980 total(indirect: By Spouse)
  • Purchase

    Common Stock

    2021-05-17$0.80/sh+18,622$14,898110,755 total
Footnotes (1)
  • [F1]Represents the purchase of 18,622 shares in multiple transactions, ranging in price from $0.7942 to $0.8097 per share, resulting in a weighted average purchase price of $0.806. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased at each price within the range.

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES